APEX R&D
ActiveSummary
APEX R&D has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5.52M and a net result of €1.28M. Equity is growing by ~21.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 2692 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Credit check for your own amount and term
Signals
Checked, nothing found (2)
Financials · fiscal year 2025, abbreviated schema
Filed annual accounts As filed with the NBB · 2025 against 2024 · 54 lines
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Show earlier events
Directors · office · real estate
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waversebaan 2763001 Leuven1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24432H0037/00V017 | Flanders | 1,523 m² | 1 · 260 m² | 14.6 m |
Linked by address, not proof of ownership
Public money · subsidies and aid
Flemish government
2022 to 2025 · 6 entries · 53,374 EUR awarded · 53,374 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | -4,079 EUR | 8,421 EUR |
| 2023 | 2 | 32,025 EUR | 44,525 EUR |
| 2022 | 2 | 25,428 EUR | 428 EUR |
Recognitions · licences · registrations
Legal Entity Identifier
Similar companies · same sector, comparable size
Company data · Crossroads Bank
Scores and ratios are computed by Checked and are not a credit decision.